alpha v2

Online Wellness Community Natural Health and Anti-Aging News
Online Wellness Community Natural Health and Anti-Aging News
healthforce.com
Avatar Image

Cancer and CoEnzyme Q10 – Improving Patient Outcomes

Coenzyme Q10 and Cancer
Enhancing Treatment Outcomes and Improving Chemotherapy Tolerability

(originally published by Dr. Julius Goepp, MD in LE Foundation magazine in 2008 – OWC staff made some editorial changes in 06-2010)

Few lay people understand that one of the reasons chemotherapy does not cure more cancers is that its inherent toxicity limits the dosage that can be administered. What this means is that even if the cancer is slowly being eradicated by the chemo drugs, the damage inflicted on healthy cells can be so severe that chemotherapy must be discontinued. A common side effect cancer victims face is chemotherapy-induced immune suppression that leaves patients susceptible to life-threatening infections.

Fortunately, research suggests that coenzyme Q10 (CoQ10) can offer critical support for those challenged with cancer, including improving the tolerability of chemotherapy and lessening its adverse impact on immune function. In addition, tantalizing evidence suggests that CoQ10 may help chemotherapy drugs more effectively battle cancer via several fascinating mechanisms. Here, we’ll explore CoQ10’s importance in combating cancer.

Coenzyme Q10 Basics

Best known in medicine today for its vital contributions to heart and brain health,1 exciting new discoveries point to broad and novel roles for CoQ10 as a “chemoprotectant” with tremendous promise as an adjuvant therapy in cancer treatment.

Early recognition of CoQ10’s potential as a cellular protectant came from the oncology laboratory of researchers studying the toxic effects of a potent chemotherapy drug, adriamycin (doxorubicin).6 Adriamycin is in the anthracycline class that kills cancer cells by damaging their DNA. At the high doses used in cancer treatment, however, adriamycin also interferes with mitochondria in healthy cells,7 causing damage to heart muscle that limits the drug’s usefulness and safety. Remarkably, when researchers treated laboratory rats first with CoQ10 and then with adriamycin, they found survival rates of 80-86%, compared with just 36-42% in animals receiving the drug alone without the supplement.

Italian researchers confirmed this effect in a particularly vulnerable group of human patients—children with cancer.8One group of children with leukemia or lymphoma received chemotherapy with anthra-cycline drugs plus CoQ10, while the other group was treated without the supplement. The researchers studied the children’s heart function using echocardiography, a means of directly viewing the beating heart and its structures with ultrasound. Under the punishing effects of the drugs, all children suffered some loss of cardiac function, but those in the CoQ10-supplemented group showed significantly less impairment than those in the drug-only group. The treating physicians concluded that their data demonstrated “a protective effect of CoQ10 on cardiac function during therapy.”

Inflammation, Oxidative Stress, and Genetic Damage – The Deadly Cycle

To understand the fundamental role that CoQ10 can play in cancer prevention and management, it’s important to recognize the intimate relationships between oxidant damage, inflammation, and the processes that initiate and promote cancer growth. Throughout life, a build-up of free radical damaged components occurs within cells, particularly during times of severe oxidant stress, such as disease and injury.

Tissue damaged by free radicals triggers a protective inflammatory response through the release of chemical signals called cytokines and chemokines. Beneficial at first and in controlled amounts, these “mediators of inflammation” eventually produce new tissue damage. With time, this inflammation-induced cycle of destruction contributes to DNA damage.

Cancer can occur when at least two conditions are met.10 First, DNA must become sufficiently damaged that a cell loses control of its own growth-regulating mechanisms (this process is called initiation of cancer). The next step, promotion, can occur when “cross-talk” between normal immune cells patrolling for cancerous cells becomes garbled by the chemical storm produced by inflammation.11 This disruption in cellular communication can allow tumor cells to proliferate. Finally, reactive oxygen species interfere with fundamental cellular controls that normally cause the programmed cell death of cancerous cells in the process known as apoptosis.11,12 By interfering with apoptosis, inflammatory cytokines render cancer cells resistant not only to natural control mechanisms but even to cancer-killing chemotherapy drugs.

CoQ10 and Cancer

Cancer is both the result and a significant cause of free-radical damage related to inflammation. A growing awareness of this critical and intimate association has led scientists to explore ways of controlling cancer growth by limiting free-radical damage. This line of thinking is a result not only of our progress in understanding how cancer develops, but also of our struggle to control the disastrous effects of chemotherapy drugs on healthy tissues. Given its strong performance as a tissue-protecting antioxidant molecule that promotes cardiovascular and brain health, it’s not surprising that cutting-edge medical researchers turned to CoQ10 as a possible means of preventing chemotherapy-related damage. What might be more surprising is that this versatile nutrient seems to actually improve the cancer-killing impact of the chemotherapy drugs themselves!

Preliminary Findings

CoQ10 became part of the oncologist’s arsenal three decades ago when animal studies demonstrated how it could protect against the burst of free-radical release resulting from adriamycin treatment of various cancers. Within a year of its first use in that setting, however, alert scientists began to notice that CoQ10 was having an independent beneficial effect—it was helping to energize immune system cells that had been suppressed by cancer, restoring their ability to fight back by attacking the cancer cells themselves (remember that the immune system is a powerful defense against cancer metastasis). This “immunostimulatory” effect was demonstrated by Japanese researchers when they used carcinogenic chemicals to produce colon cancer in rats, followed by treatment with CoQ10 or other immunostimulants. As expected, none of the immune-stimulating treatments alone prevented colon cancer from developing—but all of them significantly reduced the number of tumors and also prevented their invasion of other tissues.

Several small human trials were conducted in the 1990s, but with a regrettable lack of enthusiasm in the medical community.25 For example, the immune-stimulating powers of CoQ10 were explored by the same Austin biochemists who later attained prominence as a result of their fundamental work with the nutrient.26 When they gave CoQ10 and vitamin B6 (pyridoxine) to human subjects and measured levels of immunoglobulin G (an important antibody protein in the human immune system), they noted significant increases. Intriguingly, they also found that blood levels of the “T4-helper” cell line also increased, as did the ratio of T-helper/T-suppressor cells, indicating a significant boost in subjects’ immunologic protection against viruses and the abnormal cell surface markers associated with cancer.

In 1994, partial remission of breast cancer was noted in a group of patients in Denmark following their supplementation with CoQ10 along with other antioxidants and essential fatty acids.27 In this groundbreaking study, 32 women with breast cancer categorized as high risk, because of the spread of their tumor to the lymph nodes, took supplements of vitamins C and E plus selenium, essential fatty acids, and CoQ10 (90 mg/day). The researchers took this “combinatorial” approach using their knowledge that multiple factors act synergistically to initiate and promote cancer growth. Based on this principle the researchers hypothesized that the synergistic effects of multiple components should also be tested to evaluate their anticancer effects together. All patients in this study had already undergone surgery but were known to have residual tumor remaining. Dramatically, there were zero deaths during the study period, despite an expected mortality rate of four patients. No patient showed signs of developing new metastases, and all patients reported an improvement in the quality of life.

Still more remarkably, in that same Danish study, was the finding that six of the 32 women actually showed partial tumor regression (that is, not only did remaining tumors not grow, but they actually became smaller). Encouraged, the researchers increased the daily dose of CoQ10 in one patient to 390 mg—a month later, she had no tumor detectable on physical examination, and by the end of the following month, the tumor was entirely gone on her mammogram. The investigators then raised the dose in a second patient as well—the researchers reported that, “after three months, the patient was in excellent clinical condition and there was no residual tumor tissue.” Concluding this stunning report, the scientists noted that CoQ10’s “bioenergetic activity” (that is, its ability to protect cells from oxidant damage and to make more energy available for healthy function) may be the dominant mechanism causing these dramatic regressions of breast cancer.28

The Indian researchers in Madras also took their knowledge and skills from the laboratory to the bedside with definitive studies of CoQ10 in human cancer patients, publishing their results in 2007.29,30 They began their work with the established observation that it is the tumor metastasis, not the primary cancer, which is the cause of death in breast cancer patients. Find a way to prevent metastasis or at least slow its progression, the researchers reasoned, and one might dramatically improve outcomes for breast cancer sufferers. To test their hypothesis, they conducted two studies among a group of 84 breast cancer patients, randomly assigning them to receive a placebo or daily supplements with 100 mg CoQ10, 10 mg riboflavin, and 50 mg niacin. All patients were treated with tamoxifen as the primary chemotherapy drug as well.

In the first study, the researchers measured tumor markers, the blood proteins that reflect the degree to which a tumor has progressed and potentially spread.29 Once treated with tamoxifen, levels of tumor markers dropped significantly, as was expected. But patients treated with the CoQ10-containing supplement had still larger decreases in their tumor marker levels. From this work, the researchers concluded that the CoQ10-containing supplement “reduces… the risk of cancer recurrence and metastases.”

Not content with examining just one measure (tumor markers) of the effects of supplementation, the research group proceeded to examine the ways in which supplementation affected the various immune and tumor regulation system components that can contribute to the spread of cancer.30 Focusing on cytokines, the potent inter- and intracellular chemicals that signal inflammation and promote or allow the spread of cancer, the researchers obtained blood samples from the same 84 patients in the previous study. They also measured levels of vascular endothelial growth factor (VEGF), a tumor-promoting protein that cancer cells use to grow blood vessels. Lowering levels of all of these tumor-enhancing chemicals is a crucial step in slowing or preventing tumor spread. Again, the results were unambiguous—supplemented [CoQ10, riboflavin, and niacin] patients had significantly reduced levels of all the cytokines and VEGF, compared with those treated with tamoxifen only. Powerfully, the scientists concluded that, “such a decrease in serum cytokine levels after [CoQ10, riboflavin, and niacin] supplementation in breast cancer patients may suggest good prognosis and efficacy of the treatment, and might even offer protection from metastases and recurrence of cancer.”

These dramatic findings all point to CoQ10’s versatile immune-enhancing and tumor-reducing powers in breast cancer. But what about other, even more resistant cancers? Given the vital role of the immune system in keeping patients cancer-free after treatment of all kinds of tumors, researchers in Rome studied immune-boosting treatments for patients with one of the most deadly and treatment-resistant cancers, malignant melanoma.31 Early and aggressive surgery has been the mainstay of treatment for this deadly form of skin cancer.32 The addition of treatment with immune-boosting cytokines such as interferon-alpha and interleukin-2 has slightly improved survival but at the cost of significant side effects.33 The Rome researchers had noted that melanoma patients have low levels of CoQ10, and reasoned that the addition of the nutrient to interferon therapy might enhance its success while reducing side effects. They conducted a three-year trial of uninterrupted treatment with low-dose interferon-alpha only, or with the addition of 400 mg/day of CoQ10 in patients with early melanoma following surgical removal of the tumors. They followed the patients all the way out to 5 years following treatment. Remarkably for such a lengthy study, no patient withdrew from the trial as a result of side effects. Most importantly, the disease progressed much more slowly in the interferon plus CoQ10-treated patients, who also had a significantly reduced rate of recurrence of the tumors than the unsupplemented group.31

One of the reasons that cytokine levels are elevated in cancer patients is the powerful inflammatory response produced in normal tissues by the tumor—and, as we’ve seen, the inflammatory response is itself involved in the growth and spread of new tumor tissues. Unfortunately, many cancer chemotherapy agents produce inflammation, often as a result of the intentional oxidant damage they inflict on tumor cells and their components. Despite its beneficial effects in the treatment of breast cancer, tamoxifen is notorious for imposing oxidative stress and increasing markers of inflammation. It also disrupts patients’ lipid profiles, elevating low-density lipoprotein (LDL), triglycerides, and total cholesterol, while lowering the protective high-density lipoprotein (HDL). The Madras research group therefore set out to determine how CoQ10 affects antioxidant status and lipid profiles, reasoning that some of its benefit might be the result of restoring balance to these fundamental parameters.34,35

Not surprisingly, untreated breast cancer patients were found to have increased lipid levels and elevated levels of inflammatory oxidized fats. Treatment with tamoxifen had only a limited impact on oxidative stress, and also induced a severe elevation of triglycerides (fat molecules) in the patients’ serum. When the researchers added CoQ10, riboflavin, and niacin supplementation, however, levels of oxidized fats fell dramatically, with a concomitant increase in antioxidant levels.34

Remarkably, the tamoxifen-induced disruptions in the lipid profiles also responded to CoQ10 combination therapy. All of the lipid profile abnormalities reverted to near-normal levels after 90 days of treatment with the combination (tamoxifen plus CoQ10 and other nutrients) therapy.35

WHAT YOU NEED TO KNOW: UBIQUINOL: THE MOST ADVANCED FORM OF COQ10
In 2006, the ubiquinol form of CoQ10 was first introduced as a dietary supplement. Ubiquinol is an electron donor that is able to neutralize dangerous free radicals as soon as it is ingested—unlike ubiquinone (the only type of CoQ10 available before 2006), it requires no biochemical activation after it is consumed.

Evidence suggests that the body absorbs ubiquinol up to eight times more effectively than ubiquinone.38-40 These findings suggest that ubiquinol may offer the most bioavailable CoQ10 formulation available today.

Summary

Perhaps even more feared than the diagnosis of cancer itself are the horrendous side effects associated with chemotherapy. New discoveries show that coenzyme Q10 not only helps prevent healthy cells from undergoing malignant changes, but also protects against chemotherapy side effects and inflammatory damage inflicted on the body by cancer cells.

Coenzyme Q10 celebrated the 50th anniversary of its discovery in 2007. For most of its “lifetime” in human biology, it has been seen only as a nutrient related to cellular energy metabolism and has therefore been best known for its beneficial effects on hea

For more information on alternative complimentary cancer therapies including nutritional therapy see

http://www.onlinewellnesscommunity.com/blog/2010/06/06/complimentary-cancer-treatment/

This entry was posted in Article, Cancer
, Immune System

One Trackback

  1. [...] Co-Q10 (See http://www.onlinewellnesscommunity.com/blog/2010/06/06/cancer-and-coenzyme-q10-improving-patient-out… [...]

Post a Comment

You must be logged in to post a comment.

Featured Member Experts (click on them to view their profiles)